Collectively, the results indicate that group C2 cancer cells adapt to the presence of tumor-infiltrating lymphocytes by acquiring specific somatic mutations, MHC mutations, and genomic CNVs, and group C1 escapes immune surveillance by changing the activation and proliferation of immune cells in the immune microenvironment. Here, HLA-C is linked to neoplasm.